Literature DB >> 18657912

An evaluation of the role of smoking context on a biobehavioral index of distress tolerance.

A Bernstein1, J Trafton2, M Ilgen3, M J Zvolensky4.   

Abstract

The present study evaluated the effect of smoking deprivation on a biobehavioral index of distress tolerance, breath-holding duration, among 43 adult smokers in a repeated measures test (Session 1=smoking-as-usual, Session 2=12-h smoking deprivation). We theorized that distress tolerance is a context-dependent individual difference variable whose expression varies prospectively, within-individuals, as a function of smoking context. As predicted, participants' breath-holding duration was significantly shorter during an experimental session that immediately followed a 12-h smoking deprivation period than during a smoking-as-usual session. Furthermore, we theorized that among individuals with a pre-existing diathesis (i.e., psychiatric symptoms), smoking deprivation may activate a vulnerability process that decreases capacity to tolerate distress; in the absence of this stressor, these psychiatrically vulnerable smokers may express variable levels of distress tolerance. As predicted, we observed that level of psychiatric symptoms was significantly negatively correlated with breath-holding duration during the smoking deprivation, but not the smoking-as-usual session. These data advance our understanding of smoking and distress tolerance and the context-dependent phenomenology of distress tolerance.

Entities:  

Mesh:

Year:  2008        PMID: 18657912     DOI: 10.1016/j.addbeh.2008.06.003

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  22 in total

Review 1.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Predictors of persistent nicotine dependence among adults in the United States.

Authors:  Renee D Goodwin; Jina Pagura; Rae Spiwak; Adina R Lemeshow; Jitender Sareen
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

Review 3.  Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults.

Authors:  Teresa M Leyro; Michael J Zvolensky; Amit Bernstein
Journal:  Psychol Bull       Date:  2010-07       Impact factor: 17.737

4.  State, but not trait, measures of persistence are related to negative affect.

Authors:  Marc L Steinberg; Jill M Williams
Journal:  J Stud Alcohol Drugs       Date:  2013-07       Impact factor: 2.582

5.  Distress intolerance and withdrawal severity among daily smokers: The role of smoking abstinence expectancies.

Authors:  Rachel L Rosen; Allison M Borges; Mindy M Kibbey; Marc L Steinberg; Teresa M Leyro; Samantha G Farris
Journal:  Addict Behav       Date:  2019-07-10       Impact factor: 3.913

6.  Distress Intolerance and Smoking Topography in the Context of a Biological Challenge.

Authors:  Samantha G Farris; Elizabeth R Aston; Teresa M Leyro; Lily A Brown; Michael J Zvolensky
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

7.  Development and validation of a contextual behavioral distress intolerance task in cigarette smokers.

Authors:  Samantha G Farris; Angelo M DiBello; Michael J Zvolensky
Journal:  Addict Behav       Date:  2018-07-29       Impact factor: 3.913

8.  Factors predicting smoking in a laboratory-based smoking-choice task.

Authors:  Krysten W Bold; Haewon Yoon; Gretchen B Chapman; Danielle E McCarthy
Journal:  Exp Clin Psychopharmacol       Date:  2013-02-18       Impact factor: 3.157

9.  Distress intolerance during smoking cessation treatment.

Authors:  Samantha G Farris; Teresa M Leyro; Nicholas P Allan; Camilla S Øverup; Norman B Schmidt; Michael J Zvolensky
Journal:  Behav Res Ther       Date:  2016-08-03

10.  Acute effects of cannabis on breath-holding duration.

Authors:  Samantha G Farris; Jane Metrik
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.